Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
{{output}}
Background: Consistent with WHO recommendations, obesity is defined as BMI ≥25 kg/m2 in many Asian populations because of increased health risks at lower BMIs than in other populations. We aimed to investigate the efficacy and s... ...
